封面
市场调查报告书
商品编码
1754015

2025 年至 2033 年上市后药物警戒和医疗资讯市场报告(按类型、产品、最终用户和地区)

Post-marketing Pharmacovigilance and Medical Information Market Report by Type, Product, End User, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球上市后药物警戒与医疗资讯市场规模达 62 亿美元。展望未来, IMARC Group预计到 2033 年市场规模将达到 139 亿美元,2025-2033 年期间的成长率 (CAGR) 为 9.04%。

上市后药物警戒和医疗资讯是指药品和医疗器材上市后对其安全性和有效性进行监测的实务。它包括收集、监测和预防新药、新设备和新疗法的不良反应。它透过阐明与益处相关的风险并驳斥虚假适应症,帮助保护患者免受不必要的伤害。此外,它还协助研究人员确定整个药物製剂週期所需的措施。因此,上市后药物警戒和医疗资讯在医疗保健行业中发挥重要作用,用于评估患者和医务人员之间传递讯息的准确性。研究机构也用它来规范药物安全指南。

上市后药物警戒与医疗资讯市场趋势:

全球老年人口的成长以及糖尿病、高血压、失智症、心血管疾病和骨质疏鬆症等各种慢性疾病发生率的上升,是导致药品消费增加的关键因素之一。此外,生活方式、呼吸道和心血管感染以及神经系统和肿瘤疾病的发生率不断上升,也导致全球药品销售额不断增长。这反过来又创造了积极的市场前景。同时,药品不良反应 (ADR) 的发生率不断上升,加上先进的 ADR 报告工具的运用,正在支撑市场的成长。此外,医院、诊所、实验室和医学研究中心的扩张也刺激了全球对药品和医疗器材的需求。各国政府正在实施多项倡议,以改善医疗基础设施和药物警戒服务,并维护医疗资料库,这些倡议正在增强市场的成长。此外,领先的市场参与者正专注于外包药物警戒操作(PVO)并引入基于云端的医疗资讯系统,以实现最佳准确性、成本效率、风险缓解、领域、改进的时间表和组织敏捷性,预计这将推动市场发展。

本报告回答的关键问题

  • 全球上市后药物警戒与医疗资讯市场规模有多大? 2025-2033年全球上市后药物警戒与医疗资讯市场的预期成长率为何?
  • 推动全球上市后药物警戒与医疗资讯市场发展的关键因素有哪些?
  • COVID-19 对全球上市后药物警戒与医疗资讯市场有何影响?
  • 全球上市后药物警戒与医疗资讯市场依类型分为哪些类型?
  • 根据最终用户,全球上市后药物警戒和医疗资讯市场是如何分布的?
  • 全球上市后药物警戒和医疗资讯市场的主要区域有哪些?
  • 全球上市后药物警戒和医疗资讯市场的主要参与者/公司有哪些?

目录

第一章:前言

第二章:范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章:执行摘要

第四章:简介

  • 概述
  • 主要行业趋势

第五章:全球上市后药物警戒与医疗资讯市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章:市场细分:依类型

  • 自发报道
  • 强化ADR报告
  • 针对性的自发性报告
  • 群组事件监控
  • EHR挖掘

第七章:市场区隔:依产品

  • 图书
  • 网路媒体
  • 期刊

第八章:市场区隔:按最终用户

  • 医院
  • 研究组织

第九章:市场细分:依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔:依国家

第十章:SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章:价值链分析

第 12 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章:价格分析

第 14 章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Accenture Plc.
    • ArisGlobal
    • Cognizant Technology Solutions Corporation
    • Ergomed Plc
    • F. Hoffmann-La Roche Ltd.
    • Icon Plc
    • Parexel International Corporation
    • Pharmaceutical Product Development, Inc.
    • Wipro Ltd.
Product Code: SR112025A6454

The global post-marketing pharmacovigilance and medical information market size reached USD 6.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.9 Billion by 2033, exhibiting a growth rate (CAGR) of 9.04% during 2025-2033.

Post-marketing pharmacovigilance and medical information is the practice of monitoring the safety and efficacy of drugs and medical devices after their launch. It includes collection, surveillance, and prevention of adverse effects of new medicines, equipment, and therapies. It helps protect patients from unnecessary harm by clarifying risks concerning benefits and refuting false indications. Besides this, it assists researchers in determining required actions throughout the drug formulation cycle. As a result, post-marketing pharmacovigilance and medical information finds a considerable role in the healthcare industry to assess the accuracy of the delivered information between patients and medical professionals. It is also used in research organizations for regulating drug safety guidelines.

Post-marketing Pharmacovigilance and Medical Information Market Trends:

The growing global geriatric population and the rising occurrence of various chronic medical disorders, such as diabetes, hypertension, dementia, cardiovascular diseases, and osteoporosis, represent one of the key factors increasing the consumption of medicines. In addition, the increasing frequency of lifestyle, respiratory and cardiovascular infections, and neurological and oncological diseases are resulting in the increasing sales of drugs worldwide. This, in turn, is creating a positive market outlook. In line with this, the rising prevalence of Adverse Drug Reactions (ADRs), coupled with the incorporation of advanced ADR reporting tools, is supporting the market growth. Apart from this, the expansion of hospitals, clinics, laboratories, and medical research centers is catalyzing the demand for medications and medical devices across the globe. Moreover, governments of various countries are implementing several initiatives to improve healthcare infrastructure and pharmacovigilance services and maintain medical databases, which is strengthening the market growth. Furthermore, leading market players are focusing on outsourcing pharmacovigilance operations (PVO) and introducing cloud-based medical information systems for optimal accuracy, cost efficiency, risk mitigation, domain, improved timelines, and organizational agility, which is anticipated to drive the market.

Key Market Segmentation:

Breakup by Type:

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Breakup by Product:

  • Books
  • Online Media
  • Journals

Breakup by End User:

  • Hospitals
  • Research Organization

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc., ArisGlobal, Cognizant Technology Solutions Corporation, Ergomed Plc, F. Hoffmann-La Roche Ltd., Icon Plc, Parexel International Corporation, Pharmaceutical Product Development, Inc. and Wipro Ltd.

Key Questions Answered in This Report

  • 1.How big is the global post-marketing pharmacovigilance and medical information market?
  • 2.What is the expected growth rate of the global post-marketing pharmacovigilance and medical information market during 2025-2033?
  • 3.What are the key factors driving the global post-marketing pharmacovigilance and medical information market?
  • 4.What has been the impact of COVID-19 on the global post-marketing pharmacovigilance and medical information market?
  • 5.What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the type?
  • 6.What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the end user?
  • 7.What are the key regions in the global post-marketing pharmacovigilance and medical information market?
  • 8.Who are the key players/companies in the global post-marketing pharmacovigilance and medical information market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Post-marketing Pharmacovigilance and Medical Information Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Spontaneous Reporting
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intensified ADR Reporting
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Targeted Spontaneous Reporting
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cohort Event Monitoring
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 EHR Mining
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Books
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Online Media
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Journals
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Organization
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accenture Plc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 ArisGlobal
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cognizant Technology Solutions Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Ergomed Plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 F. Hoffmann-La Roche Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Icon Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Parexel International Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pharmaceutical Product Development, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Wipro Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials

List of Figures

  • Figure 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Major Drivers and Challenges
  • Figure 2: Global: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Product (in %), 2024
  • Figure 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Post-marketing Pharmacovigilance and Medical Information Industry: SWOT Analysis
  • Figure 78: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Value Chain Analysis
  • Figure 79: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Competitive Structure
  • Table 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Players